• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.磷酸二酯酶-5（PDE5）抑制剂在勃起功能障碍治疗中的应用
P T. 2013 Jul;38(7):407-19.
2
Non-invasive management of primary phosphodiesterase type 5 inhibitor failure in patients with erectile dysfunction.勃起功能障碍患者磷酸二酯酶 5 型抑制剂治疗失败的非侵入性管理。
Ther Adv Urol. 2009 Dec;1(5):235-42. doi: 10.1177/1756287210362069.
3
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.磷酸二酯酶 5 抑制剂治疗良性前列腺增生症下尿路症状的最新证据。
Eur Urol. 2016 Jul;70(1):124-133. doi: 10.1016/j.eururo.2015.12.048. Epub 2016 Jan 22.
4
Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.5型磷酸二酯酶抑制剂在前列腺切除术后勃起功能障碍中的应用：基础科学原理与临床应用的批判性分析
Eur Urol. 2009 Feb;55(2):334-47. doi: 10.1016/j.eururo.2008.10.028. Epub 2008 Oct 21.
5
Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.5型磷酸二酯酶（PDE5）抑制剂治疗双侧保留神经根治性前列腺切除术后勃起功能障碍的疗效和安全性。
Andrologia. 2016 Feb;48(1):20-8. doi: 10.1111/and.12405. Epub 2015 Feb 15.
6
Daily use of phosphodiesterase 5 inhibitors for erectile dysfunction and lower urinary tract symptoms.每日使用磷酸二酯酶5抑制剂治疗勃起功能障碍和下尿路症状。
Int J Impot Res. 2008 Mar-Apr;20(2):145-9. doi: 10.1038/sj.ijir.3901631. Epub 2007 Dec 13.
7
The Effect of Phosphodiesterase-type 5 Inhibitors on Erectile Function: An Overview of Systematic Reviews.5型磷酸二酯酶抑制剂对勃起功能的影响：系统评价综述
Front Pharmacol. 2021 Sep 7;12:735708. doi: 10.3389/fphar.2021.735708. eCollection 2021.
8
Efficacy and safety of short- and long-term, regular and on-demand regimens of phosphodiesterase type 5 inhibitors in treating erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.5型磷酸二酯酶抑制剂短期和长期、规律和按需治疗方案在保留神经的根治性前列腺切除术后勃起功能障碍治疗中的疗效和安全性：一项系统评价和荟萃分析
Clin Interv Aging. 2017 Feb 20;12:405-412. doi: 10.2147/CIA.S122273. eCollection 2017.
9
The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.PDE5 抑制剂单独或联合 α 受体阻滞剂治疗良性前列腺增生所致勃起功能障碍和下尿路症状的疗效：系统评价和荟萃分析。
J Sex Med. 2014 Jun;11(6):1539-45. doi: 10.1111/jsm.12499. Epub 2014 Mar 13.
10
Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.5型磷酸二酯酶抑制剂治疗勃起功能障碍：枸橼酸西地那非口腔崩解片剂型的药理学及临床影响
Clin Ther. 2017 Feb;39(2):370-377. doi: 10.1016/j.clinthera.2017.01.001. Epub 2017 Jan 28.

引用本文的文献

1
Discovery of Natural Phosphodiesterase 5 Inhibitors from Pierre Leaves Using LC-QTOF-MS.利用液相色谱-四极杆飞行时间质谱法从皮埃尔叶中发现天然磷酸二酯酶5抑制剂
Plants (Basel). 2025 May 29;14(11):1652. doi: 10.3390/plants14111652.
2
Tribulus terrestris for management of patients with erectile dysfunction: a systematic review and meta-analysis of randomized trials.刺蒺藜用于治疗勃起功能障碍患者：随机试验的系统评价和荟萃分析
Int J Impot Res. 2025 May 13. doi: 10.1038/s41443-025-01086-7.
3
Inhibitors of Cyclic Dinucleotide Phosphodiesterases and Cyclic Oligonucleotide Ring Nucleases as Potential Drugs for Various Diseases.环二核苷酸磷酸二酯酶和环寡核苷酸环核酸酶抑制剂作为多种疾病的潜在药物
Cells. 2025 Apr 30;14(9):663. doi: 10.3390/cells14090663.
4
A novel phosphodiesterase target as a therapeutic approach: inhibiting DEN-induced hepatocellular carcinoma progression.一种作为治疗方法的新型磷酸二酯酶靶点：抑制二乙基亚硝胺诱导的肝细胞癌进展。
EXCLI J. 2025 Mar 7;24:407-429. doi: 10.17179/excli2024-7941. eCollection 2025.
5
Association of Sexual Health and Mental Health in Erectile Dysfunction: Expert Opinion From the Indian Context.勃起功能障碍中性健康与心理健康的关联：来自印度背景的专家意见
Cureus. 2025 Jan 22;17(1):e77851. doi: 10.7759/cureus.77851. eCollection 2025 Jan.
6
A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction.胆碱能和磷酸二酯酶-5 抑制剂治疗糖尿病膀胱功能障碍简述。
Int J Mol Sci. 2024 Oct 4;25(19):10704. doi: 10.3390/ijms251910704.
7
Prospective, randomized, placebo-controlled, two-arm study to evaluate the efficacy of coadministration of garlic as a hydrogen sulfide donor and tadalafil in patients with erectile dysfunction not responding to tadalafil alone - A pilot study.前瞻性、随机、安慰剂对照、双臂研究，评估大蒜作为硫化氢供体与他达拉非联合给药对单独应用他达拉非反应不佳的勃起功能障碍患者的疗效 - 一项初步研究。
Indian J Pharmacol. 2024 Jul 1;56(4):242-247. doi: 10.4103/ijp.ijp_310_23. Epub 2024 Sep 10.
8
Mechanism investigation of highly selective inhibitors toward phosphodiesterase 5 and 6 via the calculation and simulation.通过计算和模拟对磷酸二酯酶5和6的高选择性抑制剂的作用机制研究
Front Chem. 2024 Aug 8;12:1400886. doi: 10.3389/fchem.2024.1400886. eCollection 2024.
9
Single and combined toxicity of tadalafil (Cilais) and microplastic in Tilapia fish (Oreochromis niloticus).他达拉非（希爱力）和微塑料对罗非鱼（奥利亚罗非鱼）的单一和联合毒性。
Sci Rep. 2024 Jun 25;14(1):14576. doi: 10.1038/s41598-024-64282-3.
10
Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis.磷酸二酯酶-5 抑制剂的使用与阿尔茨海默病风险：系统评价和荟萃分析。
Neurol Sci. 2024 Nov;45(11):5261-5270. doi: 10.1007/s10072-024-07583-9. Epub 2024 May 25.

本文引用的文献

1
Chronic low dosing of phosphodiesterase type 5 inhibitor for erectile dysfunction.慢性低剂量使用5型磷酸二酯酶抑制剂治疗勃起功能障碍。
Korean J Urol. 2012 Jun;53(6):377-85. doi: 10.4111/kju.2012.53.6.377. Epub 2012 Jun 19.
2
Chronic PDE-5 inhibition in patients with erectile dysfunction - a treatment approach using tadalafil once-daily.慢性 PDE-5 抑制在勃起功能障碍患者中的应用——每日一次使用他达拉非的治疗方法。
Expert Opin Pharmacother. 2012 Jul;13(10):1481-94. doi: 10.1517/14656566.2012.693162.
3
Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction.阿伐那非，一种用于勃起功能障碍的强效、高选择性磷酸二酯酶-5 抑制剂。
J Urol. 2012 Aug;188(2):668-74. doi: 10.1016/j.juro.2012.03.115. Epub 2012 Jun 15.
4
A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.一项评估阿伐那非治疗勃起功能障碍安全性和有效性的随机、双盲、安慰剂对照研究。
J Sex Med. 2012 Apr;9(4):1122-33. doi: 10.1111/j.1743-6109.2011.02629.x. Epub 2012 Jan 16.
5
Future prospects in the treatment of erectile dysfunction: focus on avanafil.勃起功能障碍治疗的未来前景：聚焦于阿伐那非
Drug Des Devel Ther. 2011;5:435-43. doi: 10.2147/DDDT.S15852. Epub 2011 Oct 18.
6
Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.阿伐那非，一种新型快速起效的磷酸二酯酶 5 抑制剂，用于治疗勃起功能障碍。
Expert Opin Investig Drugs. 2010 Nov;19(11):1427-37. doi: 10.1517/13543784.2010.518955. Epub 2010 Oct 13.
7
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition.治疗勃起功能障碍的新时代：慢性磷酸二酯酶 5 抑制。
BJU Int. 2010 Jun;105(12):1634-9. doi: 10.1111/j.1464-410X.2010.09244.x.
8
Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis.口服磷酸二酯酶-5抑制剂及激素治疗勃起功能障碍：一项系统评价与荟萃分析
Ann Intern Med. 2009 Nov 3;151(9):650-61. doi: 10.7326/0003-4819-151-9-200911030-00150.
9
Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction.他达拉非5毫克每日一次给药对勃起功能障碍男性的长期安全性和疗效。
J Sex Med. 2008 Sep;5(9):2160-9. doi: 10.1111/j.1743-6109.2008.00935.x. Epub 2008 Jun 28.
10
Erectile dysfunction.勃起功能障碍
J Urol. 2007 May;177(5):1675-81. doi: 10.1016/j.juro.2007.01.057.

Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.

作者信息

Huang Sharon A, Lie Janette D

出版信息

P T. 2013 Jul;38(7):407-19.

PMID:24049429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3776492/
Abstract
摘要